Atlas Trials

Everolimus in Patients With Pancreatic Neuroendocrine Tumors Metastatic to the Liver Previously Treated With Surgery

Clinical trial NCT02031536 · TERMINATED

Trial details

NCT number
NCT02031536
Sponsor
ECOG-ACRIN Cancer Research Group
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
GastrinomaGlucagonomaInsulinomaLiver MetastasesPancreatic Polypeptide TumorRecurrent Islet Cell CarcinomaSomatostatinoma
Start date
2014-04-10
Primary completion
2017-07-19
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.